Objectives: Abnormalities of bone mineral parameters are associated with cardiovascular
morbidity and mortality in patients with chronic kidney disease and the general population …

Objective—Hyperphosphatemia is a cardiovascular risk factor in patients with chronic kidney
disease. Relations of circulating calcium (Ca) and phosphorus (Pi) to long-term mortality risk …

It has already been established that in end-stage renal disease, hyperphosphatemia causes
soft tissue calcification including vascular calcifications. It has also been supported that there …

Phosphate levels are consistently linked with cardiac calcification, cardiovascular disease
(CVD), and death in populations with chronic kidney disease. In addition, mechanistic …

Background Serum phosphate is a known risk factor for cardiovascular events and mortality
in people with chronic kidney disease (CKD), however data on the association of these …

Hyperphosphatemia is a major risk factor for death, CVE, and vascular calcification among
patients with and without kidney disease. Even serum phosphate levels within the “normal …

Within the normal range, higher serum phosphate concentrations are associated with
cardiovascular events and mortality in individuals with chronic kidney disease (CKD) and in …

The association of increased serum phosphate with adverse outcomes may be mediated by
a link between higher serum phosphate and subclinical vascular disease. Common …

BACKGROUND: Although serum phosphorus, calcium, and calcium-phosphorus product
levels have been associated with cardiovascular events and mortality in patients with normal …

Abstract Background and Aim: Due to increasing evidence suggesting a link between
hyperphosphatemia and cardiovascular disease (CVD), mediated through vascular …